The Global Botanical and plant-derivative drug market is anticipated to grow from $ 26621 million in 2017 to $53850 million by 2026, at a CAGR of 8.58% between 2018 and 2026. Botanical drugs are derived from natural sources, i.e. plant, and thus have low side-effects and low cost as compared to synthetic drugs. The presence of high bioactive components in medicinal plants helps to cure the chronic diseases rapidly. The Botanical and plant-derivative drug market is primarily driven by the following factors:

GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026

Global Botanical & Plant Derivative Drug Market by Types (Terpenes, Steroids, Glycosides, Phenols & Other Types) by Therapeutic Applications (Oncology, Dermatology, Cns Disorders, Hormone Diseases, & Other) by Products & Geography

Request free sample

The Global Botanical and plant-derivative drug market are anticipated to grow from $ 26621 million in 2017 to $53850 million by 2026, at a CAGR of 8.58% between 2018 and 2026. Botanical drugs are derived from natural sources, i.e. plant, and thus have low side-effects and low cost as compared to synthetic drugs. The presence of high bioactive components in medicinal plants helps to cure chronic diseases rapidly. The Botanical and plant-derivative drug market is primarily driven by the following factors:

  • Growing applications in diseases
  • Growing FDA approvals
  • Technological development in the manufacturing process
  • Rising demand for traditional medicines
  • Growing focus on natural source medicines

Botanical And Plant Derivative Drug Market

To learn more about this report, request a free sample copy

The important driver increasing growth in the global botanical and plant-derivative drug market is its growing applications in diseases. Botanical drugs are derivative of medicinal plants. Botanical drugs contain algae and vegetable substances, along with macroscopic fungi.  Botanical and plant derivative drugs help in the treatment of various diseases, such as central nervous system disorders, infectious diseases, cardiovascular diseases, and respiratory diseases.  Botanical and plant derivative drugs are available in various forms, such as pills, tablets, and injections. Botanical drugs such as atropine aescin and berberine and Adonis ide are derivative from plants.

The Therapeutic applications of the botanical and plant derivative drug market are used extensively for various purposes. Oncology includes treatment and prevention of various types of cancers such as lung cancer, breast cancer, etc. by restricting the growth of cancer cells. The key factor responsible for the increased adoption of botanical and plant derivative drugs in dermatology is the increased prevalence of skin disorders. Several central nervous system receptors can interact with plant extracts and components that affect the pharmacology and thus play an important role in the treatment of diseases such as the central nervous disorders. Hormone diseases mainly comprise of endocrine system diseases that directly affect the endocrine system glands. Global other therapeutic applications include diseases such as respiratory diseases, joint diseases, renal diseases, dysentery, and cardiovascular diseases.

Stringent regulations regarding the use and approval of botanical drugs and limited adoption of botanical and plant derivative drugs are the major factors hindering the botanical and plant-derivative drug market. Governments across the globe have strict regulations regarding the use and approval of botanical drugs. Whether it is any pre-established botanical drug firm or any new company, all have to go through the long and strict process of drug approval. For instance, in the U.S., the marketing of any botanical drug product by any pre-established firm has to go through an over-the-counter (OTC) drug monograph. The use of botanical and plant derivative drugs is limited for curing only a few diseases such as central nervous system disorders and respiratory and cardiovascular diseases. The reason behind their low adoption in lethal diseases such as cancers, strokes, Alzheimer’s, and others is their low efficacy and efficiency.

The Global Botanical and plant-derivative drug market segments include types, therapeutic applications, and products.

Types are segmented into:

  • Terpenes
  • Steroids
  • Glycosides
  • Phenols
  • Other types

Therapeutic applications are segmented into:

  • Oncology
  • Dermatology
  • CNS disorders
  • Hormone diseases
  • Other therapeutic applications

Products are segmented into:

  • Herbal/traditional topical analgesics
  • Herbal/traditional cough, cold and allergy (hay fever) remedies
  • Herbal/traditional digestive remedies
  • Herbal/traditional dermatological
  • Herbal/traditional pediatric dietary supplements
  • Herbal/traditional dietary supplements
  • Herbal/traditional tonics

This report covers the present market conditions and the growth prospects of the global botanical and plant-derivative drug market for 2018-2026 and considered the revenue generated through the sales of botanical and plant for types, therapeutic applications and products to calculate the market size by considering 2017 as the base year.

Geographically, the global botanical and plant-derivative drug market has been segmented on the basis of four major regions, which include:

The Botanical and plant-derivative drug market in the Asia Pacific is expected to hold the largest share by 2025, possibly because of the growing applications of botanical & plant derivative drugs in countries such as India, China, Japan, South Korea, and Australia. The botanical & plant derivative drugs are majorly used for the treatment of respiratory diseases and infectious diseases which mainly include Tuberculosis, Asthma, and Bronchitis. Countries in the Asia-Pacific market such as China and Australia have a high prevalence rate of these diseases; which in turn is escalating the adoption of botanical and plant derivative drugs, as they are less toxic as compared to conventional medicines.

The botanical and plant-derivative drug market is segmented on the basis of types which are sub-divided into terpenes, steroids, glycosides, phenols and others and is also segmented on the basis  of products which are sub-divided into herbal/traditional topical analgesics, cold and allergy (hay fever) remedies, herbal/traditional dietary supplements, herbal/traditional cough, herbal/traditional dermatological, herbal/traditional paediatric dietary supplements, herbal/traditional digestive remedies, herbal/traditional tonics. Terpenes are a diverse class of organic compounds that are derived from a variety of plants and are also produced by some insects such as swallowtail butterflies or termites who produce terpenes from their osmeteria. Steroids such as estradiol and natural androgens (testosterone) are the organic compounds that help to regulate various bodily functions. Glycosides are organic compounds, derivative from a plant source that gives one or more sugar moieties (a part of the molecule) along with anon sugar moiety on enzymatic hydrolysis. Phenolic compounds are extracted from a major class of secondary metabolites that are distributed in the plant kingdom, and they occur as aglycones, monomers, constituting a highly polymerized structures. Analgesic drugs act in various ways on the peripheral and central nervous systems. Homemade medications for hay infection can rapidly decrease periodic allergy responses, providing respite from indications such as itching, sneezing, runny nose, and coughing and congestion. Herbal medicines and dietary supplements play significant parts in health care. Minerals and vitamins are also significant, as they are essential for bodily functions and enzymatic reactions. The dearth of these amalgams can lead to deficiency associated diseases.

The major market players of the global botanical and plant-derivative drug market are:

  • ABBOTT LABORATORIES
  • BIONOVA
  • ELI LILLY AND COMPANY
  • LUPIN LTD
  • PFIZER

Company Profiles covers the analysis of important players.

Abbott Laboratories is a global manufacturer and seller of healthcare products. The company offers branded generic pharmaceuticals to cure pancreatic exocrine insufficiency; biliary spasm; irritable bowel syndrome, gynecological disorders; intrahepatic cholestasis or depressive symptoms; hormone replacement therapy, gynecological disorders, dyslipidemia, hypothyroidism, dyslipidemia, Ménière’s disease and vestibular vertigo, fever, pain and inflammation, anti-infective clarithromycin; migraine, influenza vaccines, cardiovascular and metabolic products; as well as products to regulate physiological rhythm of the colon. Pfizer is another well-known pharmaceutical company, headquartered in New York, United States. The company was established in 1849 by Charles Pfizer and Charles F. Erhart.  It is one of the world’s largest pharmaceutical companies. The company is majorly engaged in the development and production of vaccines and medicines for a wide range of medical applications such as immunology, diabetology/endocrinology, cardiology, oncology, and neurology.

Key Findings of the Global botanical and plant-derivative drug market:

  • The Asia Pacific leads the global botanical and plant derivative drug market
  • India botanical and plant derivative drugs market to offer great opportunities
  • Glycosides are quickly rising market in terms of types
  • Oncology holds the largest market share in terms of therapeutic application
  • Herbal/traditional topical analgesics product is growing rapidly
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • ASIA PACIFIC LEADS THE GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET
      • INDIA BOTANICAL AND PLANT DERIVATIVE DRUGS MARKET TO OFFER GREAT OPPORTUNITIES
      • GLYCOSIDES IS A QUICKLY RISING MARKET IN TERMS OF TYPES
      • ONCOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF THERAPEUTIC APPLICATION
      • HERBAL/TRADITIONAL TOPICAL ANALGESICS PRODUCT DEMAND IS GROWING RAPIDLY
  1. MARKET DYNAMICS
    • DRIVERS
      • GROWING APPLICATIONS IN DISEASES
      • GROWING FDA APPROVALS
      • TECHNOLOGICAL DEVELOPMENT IN THE MANUFACTURING PROCESS
      • RISING DEMAND FOR TRADITIONAL MEDICINES
      • GROWING FOCUS TOWARDS NATURAL SOURCE MEDICINES
    • RESTRAINTS
      • STRINGENT REGULATIONS REGARDING THE USE AND APPROVAL OF BOTANICAL DRUGS
      • LIMITED ADOPTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
    • OPPORTUNITIES
      • RISING FDA APPROVALS FOR BOTANICAL DRUGS
      • ESCALATING USE OF BOTANICAL DRUGS
      • INCREASING INVESTMENT IN ASIA PACIFIC
    • CHALLENGES
      • PRESENCE OF SUBSTITUTES FOR BOTANICAL & PLANT DERIVATIVE DRUG
      • TOXICITY RELATED ISSUES AND SAFETY CONCERNS
  1. MARKET SEGMENTATION
    • MARKET BY TYPES 2018-2026
      • TERPENES
      • STEROIDS
      • GLYCOSIDES
      • PHENOLS
      • OTHER TYPES
    • MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
      • ONCOLOGY
      • DERMATOLOGY
      • CNS DISORDERS
      • HORMONE DISEASES
      • OTHER THERAPEUTIC APPLICATIONS
    • MARKET BY PRODUCTS 2018-2026
      • HERBAL/TRADITIONAL TOPICAL ANALGESICS
      • HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
      • HERBAL/TRADITIONAL DIGESTIVE REMEDIES
      • HERBAL/TRADITIONAL DERMATOLOGICAL
      • HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
      • HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
      • HERBAL/TRADITIONAL TONICS
  1. KEY ANALYTICS
    • MANUFACTURING PROCESS
    • VALUE CHAIN ANALYSIS
    • LEGAL, POLICY AND REGULATORY FRAMEWORK
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREATS OF SUBSTITUTE PRODUCT
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
  2. GEOGRAPHIC ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIES
      • MERGER & ACQUISITION
      • PARTNERSHIP & COLLABORATION
      • EXPANSION & INVESTMENT
    • MARKET SHARE ANALYSIS
    • KEY COMPANIES ANALYSIS
  2. COMPANY PROFILE
    • ABBOTT LABORATORIES
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ANALYTICAL DISCOVERY GMBH
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • BAYER HEALTHCARE LLC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • BOEHRINGER INGELHEIM
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • BIONOVA
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • BRISTOL-MYERS SQUIBB
      • OVERVIEW
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • CURA PHARM
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • WILLMAR SCHWABE GMBH & CO. KG
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • ELI LILLY AND COMPANY
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • GLAXOSMITHKLINE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • GLENMARK PHARMACEUTICALS LTD.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • INDENA VIALE ORTLES
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • LUPIN LTD
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • MEDIGENE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • NOVARTIS INTERNATIONAL AG
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • PFIZER
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • PIRAMAL PHYTOCARE LTD.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • RANBAXY LABORATORIES LTD (ACQUIRED BY SUN PHARMACEUTICALS LTD)
      • OVERVIEW
      • PRODUCTION PORTFOLIO
      • STRATEGIC INITIATIVE-
      • SCOT ANALYSIS
    • SANOFI
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • TASLY PHARMACEUTICALS INC.
      • OVERVIEW
      • PRODUCTION PORTFOLIO
      • SCOT ANALYSIS

 

LIST OF TABLES

TABLE 1       GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 2       GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY TYPES 2018-2026 ($ MILLION)

TABLE 3       GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 4       GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 5       GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 6       GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 7       GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)

TABLE 8       GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)

TABLE 9       GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 10     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 11     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 12     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 13     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 14     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET, BY PRODUCT 2018-2026 ($ MILLION)

TABLE 15     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 16     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 17     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 18     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 19     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 20     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 21     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 22     GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 23     NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

TABLE 24     EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

TABLE 25     ASIA-PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

TABLE 26     REST OF WORLD BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

 

FIGURE LIST

FIGURE 1     ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 2     INDIA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 3     GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)

FIGURE 4     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES 2018-2026 ($ MILLION)

FIGURE 5     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)

FIGURE 6     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)

FIGURE 7     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS 2018-2026 ($ MILLION)

FIGURE 8     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)

FIGURE 9     GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY 2018-2026 ($ MILLION)

FIGURE 10   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY 2018-2026 ($ MILLION)

FIGURE 11   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS 2018-2026 ($ MILLION)

FIGURE 12   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE 2018-2026 ($ MILLION)

FIGURE 13   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)

FIGURE 14   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS 2018-2026 ($ MILLION)

FIGURE 15   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES 2018-2026 ($ MILLION)

FIGURE 16   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES 2018-2026 ($ MILLION)

FIGURE 17   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS 2018-2026 ($ MILLION)

FIGURE 18   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)

FIGURE 19   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)

FIGURE 20   GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS 2018-2026 ($ MILLION)

FIGURE 21   EVOLUTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS

FIGURE 22   NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 23   UNITED STATES BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 24   CANADA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 25   UNITED KINGDOM BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 26   FRANCE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 27   GERMANY BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 28   SPAIN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 29   ITALY BOTANICAL PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 30   REST OF EUROPE BOTANICAL &PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 31   CHINA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 32   INDIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 33   JAPAN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 34   AUSTRALIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 35   SOUTH KOREA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 36   REST OF ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 37   LATIN AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 38   MIDDLE EAST & AFRICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

FIGURE 39   GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET SHARE 2017

  1. MARKET SEGMENTATION
    • MARKET BY TYPES 2018-2026
      • TERPENES
      • STEROIDS
      • GLYCOSIDES
      • PHENOLS
      • OTHER TYPES
    • MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
      • ONCOLOGY
      • DERMATOLOGY
      • CNS DISORDERS
      • HORMONE DISEASES
      • OTHER THERAPEUTIC APPLICATIONS
    • MARKET BY PRODUCTS 2018-2026
      • HERBAL/TRADITIONAL TOPICAL ANALGESICS
      • HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
      • HERBAL/TRADITIONAL DIGESTIVE REMEDIES
      • HERBAL/TRADITIONAL DERMATOLOGICAL
      • HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
      • HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
      • HERBAL/TRADITIONAL TONICS
  1. GEOGRAPHIC ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type